Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Zelpultide alfa by Airway Therapeutics for Bronchopulmonary Dysplasia: Likelihood of Approval
Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Bronchopulmonary Dysplasia. According to GlobalData,...